Pay in 4 interest-free payments of $5.41 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
The glucagon-like peptide-1 receptor agonist exendin 4 has a protective role in ischemic injury of lean and steatotic liver by inhibiting cell death and stimulating lipolysis
The hope is that results will be available for regulators to review by the end of 2025
Synergistic metabolic effect Some products contain ingredients such as caffeine and methylnicotinate esters, which can activate adenylate cyclase (AC), increase intracellular cAMP levels, and thereby activate hormone-sensitive lipase (HSL), accelerating fat mobilization
WADA Prohibition The World Anti-Doping Agency classifies both peptides as prohibited substances: Both listed under Section S0 (Non-Approved Substances) Prohibited at all times (in and out of competition) No Therapeutic Use Exemptions (TUEs) available for either peptide Detection methods under development for anti-doping testing TB-500 and thymosin beta-4 explicitly banned since 2011 WADAs position reflects that neither peptide has regulatory approval from any health authority worldwide
The simplest way to understand the distinction: NAD+ is more like cellular energy and repair currency, while MOTS-c is more like a mitochondrial signal that may help regulate metabolic response
US$ 21.53
US$ 23.72
US$ 21.84
US$ 27.09
US$ 22.66
US$ 29.49
US$ 23.99
US$ 21.22
US$ 24.18
US$ 25.67
US$ 22.65
US$ 26.82
